Inovio Pharmaceuticals Inc (NASDAQ:INO)

3.81
Delayed Data
As of Feb 19
 -0.41 / -9.72%
Today’s Change
1.92
Today|||52-Week Range
5.95
+15.45%
Year-to-Date
Here's Why Inovio Pharmaceuticals Popped Today
Feb 18 / MotleyFool.com - Paid Partner Content
Here's Why Inovio Pharmaceuticals Stock Rocketed Higher Today
Feb 13 / MotleyFool.com - Paid Partner Content
Sanofi Gets Backing From U.S. Government to Develop a COVID-19 Vaccine
Feb 18 / MotleyFool.com - Paid Partner Content
Here's Why Inovio Pharmaceuticals Jumped Higher Today
Feb 10 / MotleyFool.com - Paid Partner Content
The FDA Has a Plan to Deal With the Coronavirus
Feb 17 / MotleyFool.com - Paid Partner Content
Could These 5 Stocks Benefit From the Coronavirus Outbreak?
Feb 10 / MotleyFool.com - Paid Partner Content
Is Inovio Pharmaceuticals a Screaming Buy?
Feb 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close4.22
Today’s open4.21
Day’s range3.61 - 4.29
Volume14,385,414
Average volume (3 months)4,167,914
Market cap$416.0M
Data as of 4:00pm ET, 02/19/2020

Growth & Valuation

Earnings growth (last year)+2.98%
Earnings growth (this year)-0.82%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-27.80%
P/E ratioNM
Price/Sales12.14
Price/Book4.65

Competitors

 Today’s
change
Today’s
% change
FULCFulcrum Therapeutics...-1.31-7.08%
PRQRProQR Therapeutics N...-0.37-4.09%
----
PGNXProgenics Pharmaceut...-0.16-3.40%
Data as of 4:00pm ET, 02/19/2020

Financials

Next reporting dateMarch 25, 2020
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$30.5M
Annual profit (last year)-$97.0M
Net profit margin-318.12%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Plymouth Meeting, Pennsylvania

Forecasts